CB24

ICD-11 MMS 2026-01

Chylous effusion

Description

A chylous effusion (chylothorax) is defined by the presence of chyle in the pleural space resulting from obstruction or disruption of the thoracic duct or one of its major tributaries. A triglyceride concentration > 110 mg/dL is virtually diagnostic, but the presence of chylomicrons confirms the diagnosis. However, a chylothorax defined by these criteria represents a heterogeneous group of clinical entities. The presence of chylomicrons or triglyceride levels > 110 mg/dL in a pleural effusion should be considered evidence of chyle leakage of indeterminate clinical significance. Many cases of a chylous effusion may be associated with other causes of pleural fluid formation.

Index terms

  • Chylous effusion
  • chylothorax
  • pleurisy with chylous effusion
Show allHide
  • Cholesterol pleural effusion
  • cholesterol effusion
  • cholesterol pleurisy
  • chyliform effusion
  • pseudochylothorax
  • pseudochylous effusion

Exclusions from above levels

  • 01 – Certain infectious or parasitic diseases
  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth and the puerperium
Show allHide
  • 19 – Certain conditions originating in the perinatal period
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • CB20 – Pleural plaque
  • CB21 – Pneumothorax
  • CB22 – Diseases of mediastinum, not elsewhere classified
  • CB23 – Disorders of diaphragm
  • CB25 – Fibrothorax
  • CB26 – Haemothorax
  • CB27 – Pleural effusion
  • CB2Y – Other specified pleural, diaphragm or mediastinal disorders
  • CB2Z – Pleural, diaphragm or mediastinal disorders, unspecified

Foundation entity

Chylous effusion – http://id.who.int/icd/entity/693433074

Allowed postcoordination axes

Part of: 12: Diseases of the respiratory system